jangeissler

24 Followers

patient advocacy patient empowerment cml patient involvement eupati patientenvertreter compliance wecanadvocate wecan social media chronic myeloid leukemia patientensicht adherence cml advocates network transparency asco18 #asco18 esoadvocates esoadvocate research medicine drug development qlq qol quality of life lebensqualität forschung arzneimittel deutsche cml-allianz chronische myeloische leukämie cml-allianz advocacy patients academy health research soziale medien patients rights clinical research clinical trial risks and benefits patients perspective klinische prüfungen klinische studien krebs onkologie amnog patientenvertreter patienten concordance efgcp epatient e-patient patient

Aktivität
Info

A snapshot of EUPATI: Why the educated patient is so vital to success in clinical trials - Jan Geissler - EUPATI Director

Vor 11 Jahren • 888 Aufrufe

Launch auf the European Cancer Patients Bill of Rights: Addressing the unequal nature of cancer: patient rights take centre stage

Vor 10 Jahren • 1289 Aufrufe

SmartStart Course: Information and sharing: Online tools and social media tactics - Hands-on use of websites, forums, Facebook, Twitter, videos, slide sharing, virtual spaces for advocacy

Vor 8 Jahren • 1062 Aufrufe

jangeissler

Präsentationen

2010 11 13 european cme forum jan geissler 1.5

Giora Sharf - EHA2011 - Adherence - Patient Perspective

EUPATI launch meeting - Michel Goldman IMI

EUPATI Launch Meeing: Anders Olauson

EUPATI Launch Meeting - Jan Geissler

EUPATI Launch Meeting - Per Spindler

EUPATI Launch Meeting - Klingmann

European Patients Academy - Presentation of Jan Geissler at EPF AGM

The emergence of the e-patient

The e-patient: empowered or overwhelmed? Patient's perspective on new technologies

A snapshot of EUPATI: Why the educated patient is so vital to success in clinical trials - Jan Geissler - EUPATI Director

Non-adherence In Chronic Myeloid Leukemia: Results Of A Global Survey Of 2546 Cml Patients In 79 Countries

Patientennutzen stärker in den Fokus rücken - Jan Geissler - DGHO-Pressekonferenz 21.08.2013

Warum Studien für uns Patienten so wichtig sind - Jan Geissler

Non-adherence of CML patients - Results of the global survey of the CML Advocates Network (Giora Sharf)

Harms and Benefits in Health Research - A patients' view (Jan Geissler)

Launch auf the European Cancer Patients Bill of Rights: Addressing the unequal nature of cancer: patient rights take centre stage

Education of patients (advocates) on R&D: European Patients’ Academy EUPATI (Jan Geissler)

Patients as empowered partners? Experience about the Expo at the European Cancer Congress 2013

Social media use in patient advocacy - some practical examples from the CML Advocates Network

Effektive Zusammenarbeit im Kontext der EU-Verordnung im besten Sinne der Patienten

Patient-based evidence from the patient perspective

Forschung ohne Patienten? Patientenperspektive zur Gründung der Deutschen CML-Allianz

CML: Patienteninformation

Patient involvement in R&D - setting the scene, current status and future plans: A Patient Perspective (Jan Geissler)

SmartStart Course: Information and sharing: Online tools and social media tactics - Hands-on use of websites, forums, Facebook, Twitter, videos, slide sharing, virtual spaces for advocacy

CML-Generika: Überblick und internationale Erfahrungen

Wie können Patienten zur Deutschen CML-Allianz beitragen?

Leukämie-Online und CML Advocates Network: Überblick über Aktivitäten 2014-2015

Wie funktionieren die Entwicklungsprozesse neuer Therapien?